c-erbB-2 oncoprotein: A potential biomarker of advanced prostate cancer
- 15 February 1997
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 30 (3) , 195-201
- https://doi.org/10.1002/(sici)1097-0045(19970215)30:3<195::aid-pros8>3.0.co;2-l
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Expression of p160erbB-3 and p185erbB-2 in Prostatic Intraepithelial Neoplasia and Prostatic AdenocarcinomaJNCI Journal of the National Cancer Institute, 1994
- Overexpression of Her-2/Neu may be an Indicator of Poor Prognosis in Prostate CancerJournal of Urology, 1993
- Expression of C-ERBB-2 Gene Product in Urinary Bladder CancerJournal of Urology, 1991
- Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185
erb
B2
Science, 1990
- Amplification and expression of the c‐erb B‐2/neu proto‐oncogene in human bladder cancerMolecular Carcinogenesis, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase ActivityScience, 1986
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- The neu Gene: an erb B-Homologous Gene Distinct from and Unlinked to the Gene Encoding the EGF ReceptorScience, 1985